The home-collected vaginal samples can be shipped to CLIA-certified labs for testing on the Roche Cobas system.

Last week, readers were most interested in a story about Castle Biosciences' buy of Previse and its plans to expand its gastrointestinal diagnostic test offerings.

NEW YORK – The World Health Organization announced on Friday that its Medicines Patent Pool has sublicensed technology for rapid diagnostic testing to Nigeria’s Codix Bio. The agreement will ...

Kuppusamy noted that Quest does offer testing, and advanced diagnostic testing in particular, through its Global Diagnostics ...

NEW YORK – Although it had multiple products with regulatory clearance and technology that had been validated by outside users, Accelerate Diagnostics' inability to attract buyers for its instruments ...

NEW YORK – Eight German associations are calling for changes to be made to the European In Vitro Diagnostics Regulation (IVDR ...

The Diagnostics and Spatial Biology segment's revenues were up 2 percent compared to the prior-year quarter, while Protein Sciences revenues rose 6 percent.

NEW YORK – Sera Prognostics said after the close of the market on Wednesday that it recorded revenues of $38,000 during the first quarter, up from no revenues a year earlier, and the firm has recently ...

NEW YORK – Accelerate Diagnostics announced Thursday that it has filed for Chapter 11 bankruptcy protection in the US Bankruptcy Court for the District of Delaware and will sell its assets through a ...

NEW YORK — Exagen, a developer of autoimmune testing technologies, said on Thursday it expects to raise around $17.6 million through a public offering of its common stock. The company said that it has ...

Congress has passed delays to PAMA implementation, but such a pause could be less likely this year, warn industry stakeholders.